Literature DB >> 26307177

Association of HLA-DRB1 genetic variants with the persistence of atopic dermatitis.

David J Margolis1, Nandita Mitra2, Brian Kim3, Jayanta Gupta4, Ole J Hoffstad2, Maryte Papadopoulos5, Bradley Wubbenhorst6, Katherine L Nathanson7, Jamie L Duke8, Dimitri S Monos9, Malek Kamoun10.   

Abstract

Atopic dermatitis (AD) is a waxing and waning illness of childhood that is likely caused by interactions between an altered skin barrier and immune dysregulation. The goal of our study was to evaluate the association of DRB1 genetic variants and the persistence of AD using whole exome sequencing and high resolution typing. DRB1 was interrogated based on previous reports that utilized high throughput techniques. We evaluated an ongoing nation-wide long-term cohort of children with AD in which patients are asked every 6months about their medication use and their AD symptoms. In total, 87 African-American and 50 European-American children were evaluated. Genetic association analysis was performed using a software tool focusing on amino acid variable positions shared by HLA-DRB1 alleles covering the antigen presenting domain. Amino acid variations at position 9 (pocket 9), position 26, and position 78 (pocket 4) were marginally associated with the prevalence of AD. However, the odds ratio was 0.30 (0.14, 0.68; p=0.003) for residue 78, 0.27 (0.10, 0.69; p=0.006) for residue 26 and not significant for residue 9 with respect to the persistence of AD. In conclusion, amino acid variations at peptide-binding pockets of HLA-DRB1 were associated with the persistence of AD in African-American children.
Copyright © 2015 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atopic dermatitis; HLA alleles

Mesh:

Substances:

Year:  2015        PMID: 26307177      PMCID: PMC4593755          DOI: 10.1016/j.humimm.2015.08.003

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  49 in total

1.  SKDM human leukocyte antigen (HLA) tool: A comprehensive HLA and disease associations analysis software.

Authors:  Stathis Kanterakis; Eleni Magira; Kenneth D Rosenman; Milton Rossman; Keyur Talsania; Dimitri S Monos
Journal:  Hum Immunol       Date:  2008-07-02       Impact factor: 2.850

2.  Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches.

Authors:  Robert Sidbury; Wynnis L Tom; James N Bergman; Kevin D Cooper; Robert A Silverman; Timothy G Berger; Sarah L Chamlin; David E Cohen; Kelly M Cordoro; Dawn M Davis; Steven R Feldman; Jon M Hanifin; Alfons Krol; David J Margolis; Amy S Paller; Kathryn Schwarzenberger; Eric L Simpson; Hywel C Williams; Craig A Elmets; Julie Block; Christopher G Harrod; Wendy Smith Begolka; Lawrence F Eichenfield
Journal:  J Am Acad Dermatol       Date:  2014-09-26       Impact factor: 11.527

3.  Effects of an anti-TSLP antibody on allergen-induced asthmatic responses.

Authors:  Gail M Gauvreau; Paul M O'Byrne; Louis-Philippe Boulet; Ying Wang; Donald Cockcroft; Jeannette Bigler; J Mark FitzGerald; Michael Boedigheimer; Beth E Davis; Clapton Dias; Kevin S Gorski; Lynn Smith; Edgar Bautista; Michael R Comeau; Richard Leigh; Jane R Parnes
Journal:  N Engl J Med       Date:  2014-05-20       Impact factor: 91.245

4.  Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies.

Authors:  Lawrence F Eichenfield; Wynnis L Tom; Timothy G Berger; Alfons Krol; Amy S Paller; Kathryn Schwarzenberger; James N Bergman; Sarah L Chamlin; David E Cohen; Kevin D Cooper; Kelly M Cordoro; Dawn M Davis; Steven R Feldman; Jon M Hanifin; David J Margolis; Robert A Silverman; Eric L Simpson; Hywel C Williams; Craig A Elmets; Julie Block; Christopher G Harrod; Wendy Smith Begolka; Robert Sidbury
Journal:  J Am Acad Dermatol       Date:  2014-05-09       Impact factor: 11.527

5.  Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population.

Authors:  Tomomitsu Hirota; Atsushi Takahashi; Michiaki Kubo; Tatsuhiko Tsunoda; Kaori Tomita; Masafumi Sakashita; Takechiyo Yamada; Shigeharu Fujieda; Shota Tanaka; Satoru Doi; Akihiko Miyatake; Tadao Enomoto; Chiharu Nishiyama; Nobuhiro Nakano; Keiko Maeda; Ko Okumura; Hideoki Ogawa; Shigaku Ikeda; Emiko Noguchi; Tohru Sakamoto; Nobuyuki Hizawa; Koji Ebe; Hidehisa Saeki; Takashi Sasaki; Tamotsu Ebihara; Masayuki Amagai; Satoshi Takeuchi; Masutaka Furue; Yusuke Nakamura; Mayumi Tamari
Journal:  Nat Genet       Date:  2012-10-07       Impact factor: 38.330

6.  Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization.

Authors:  Jonathan I Silverberg; Eric L Simpson
Journal:  Pediatr Allergy Immunol       Date:  2013-06-16       Impact factor: 6.377

7.  Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms.

Authors:  Pedro A Reche; Ellis L Reinherz
Journal:  J Mol Biol       Date:  2003-08-15       Impact factor: 5.469

8.  The HLA-DRB1 Polymorphism is Associated With Atopic Dermatitis, but not Egg Allergy in Korean Children.

Authors:  Hwayoung Park; Kangmo Ahn; Myoung Hee Park; Sang Il Lee
Journal:  Allergy Asthma Immunol Res       Date:  2012-03-07       Impact factor: 5.764

9.  Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis.

Authors:  Lavinia Paternoster; Marie Standl; Chih-Mei Chen; Adaikalavan Ramasamy; Klaus Bønnelykke; Liesbeth Duijts; Manuel A Ferreira; Alexessander Couto Alves; Jacob P Thyssen; Eva Albrecht; Hansjörg Baurecht; Bjarke Feenstra; Patrick M A Sleiman; Pirro Hysi; Nicole M Warrington; Ivan Curjuric; Ronny Myhre; John A Curtin; Maria M Groen-Blokhuis; Marjan Kerkhof; Annika Sääf; Andre Franke; David Ellinghaus; Regina Fölster-Holst; Emmanouil Dermitzakis; Stephen B Montgomery; Holger Prokisch; Katharina Heim; Anna-Liisa Hartikainen; Anneli Pouta; Juha Pekkanen; Alexandra I F Blakemore; Jessica L Buxton; Marika Kaakinen; David L Duffy; Pamela A Madden; Andrew C Heath; Grant W Montgomery; Philip J Thompson; Melanie C Matheson; Peter Le Souëf; Beate St Pourcain; George Davey Smith; John Henderson; John P Kemp; Nicholas J Timpson; Panos Deloukas; Susan M Ring; H-Erich Wichmann; Martina Müller-Nurasyid; Natalija Novak; Norman Klopp; Elke Rodríguez; Wendy McArdle; Allan Linneberg; Torkil Menné; Ellen A Nohr; Albert Hofman; André G Uitterlinden; Cornélia M van Duijn; Fernando Rivadeneira; Johan C de Jongste; Ralf J P van der Valk; Matthias Wjst; Rain Jogi; Frank Geller; Heather A Boyd; Jeffrey C Murray; Cecilia Kim; Frank Mentch; Michael March; Massimo Mangino; Tim D Spector; Veronique Bataille; Craig E Pennell; Patrick G Holt; Peter Sly; Carla M T Tiesler; Elisabeth Thiering; Thomas Illig; Medea Imboden; Wenche Nystad; Angela Simpson; Jouke-Jan Hottenga; Dirkje Postma; Gerard H Koppelman; Henriette A Smit; Cilla Söderhäll; Bo Chawes; Eskil Kreiner-Møller; Hans Bisgaard; Erik Melén; Dorret I Boomsma; Adnan Custovic; Bo Jacobsson; Nicole M Probst-Hensch; Lyle J Palmer; Daniel Glass; Hakon Hakonarson; Mads Melbye; Deborah L Jarvis; Vincent W V Jaddoe; Christian Gieger; David P Strachan; Nicholas G Martin; Marjo-Riitta Jarvelin; Joachim Heinrich; David M Evans; Stephan Weidinger
Journal:  Nat Genet       Date:  2011-12-25       Impact factor: 38.330

10.  High-density genotyping study identifies four new susceptibility loci for atopic dermatitis.

Authors:  David Ellinghaus; Hansjörg Baurecht; Jorge Esparza-Gordillo; Elke Rodríguez; Anja Matanovic; Ingo Marenholz; Norbert Hübner; Heidi Schaarschmidt; Natalija Novak; Sven Michel; Laura Maintz; Thomas Werfel; Ulf Meyer-Hoffert; Melanie Hotze; Holger Prokisch; Katharina Heim; Christian Herder; Tomomitsu Hirota; Mayumi Tamari; Michiaki Kubo; Atsushi Takahashi; Yusuke Nakamura; Lam C Tsoi; Philip Stuart; James T Elder; Liangdan Sun; Xianbo Zuo; Sen Yang; Xuejun Zhang; Per Hoffmann; Markus M Nöthen; Regina Fölster-Holst; Juliane Winkelmann; Thomas Illig; Bernhard O Boehm; Richard H Duerr; Carsten Büning; Stephan Brand; Jürgen Glas; Maeve A McAleer; Caoimhe M Fahy; Michael Kabesch; Sara Brown; W H Irwin McLean; Alan D Irvine; Stefan Schreiber; Young-Ae Lee; Andre Franke; Stephan Weidinger
Journal:  Nat Genet       Date:  2013-06-02       Impact factor: 38.330

View more
  5 in total

1.  Predictive in silico binding algorithms reveal HLA specificities and autoallergen peptides associated with atopic dermatitis.

Authors:  Jan J Gong; David J Margolis; Dimitrios S Monos
Journal:  Arch Dermatol Res       Date:  2020-03-09       Impact factor: 3.017

Review 2.  Which Way Do We Go? Complex Interactions in Atopic Dermatitis Pathogenesis.

Authors:  Garrett J Patrick; Nathan K Archer; Lloyd S Miller
Journal:  J Invest Dermatol       Date:  2020-09-15       Impact factor: 8.551

3.  HLA Class I Polymorphisms Influencing Both Peptide Binding and KIR Interactions Are Associated with Remission among Children with Atopic Dermatitis: A Longitudinal Study.

Authors:  David J Margolis; Nandita Mitra; Brian S Kim; Jamie L Duke; Ron A Berna; Ole J Hoffstad; Jenna R Wasserman; Deborah A Ferriola; Tim L Mosbruger; Bradley S Wubbenhorst; Kathrine L Nathanson; Dimitri S Monos
Journal:  J Immunol       Date:  2021-04-16       Impact factor: 5.422

4.  Human leukocyte antigen class-I variation is associated with atopic dermatitis: A case-control study.

Authors:  D J Margolis; N Mitra; J L Duke; R Berna; J D Margolis; O Hoffstad; B S Kim; A C Yan; A L Zaenglein; Z Chiesa Fuxench; A Dinou; J Wasserman; N Tairis; T L Mosbruger; D Ferriola; Georgios Damianos; Ioanna Kotsopoulou; D S Monos
Journal:  Hum Immunol       Date:  2021-04-17       Impact factor: 2.211

5.  Association of FLG single nucleotide variations with clinical phenotypes of atopic dermatitis.

Authors:  Myungshin Kim; Jaeeun Yoo; Jiyeon Kim; Joonhong Park; Eunhee Han; Woori Jang; Hyojin Chae; Ji Hyun Lee; Young Min Park; Yonggoo Kim
Journal:  PLoS One       Date:  2017-12-27       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.